Kojic Acid in Brightening Skincare

Kojic acid has been a brightening ingredient for decades, which is both its strength and its problem. It is well known to formulators and to consumers, and it is also one of the ingredients most often used badly: too high a dose, in a pack that lets light in, with a claim that the market does not allow. A short specification covers most of the risk.

1. What it does

Kojic acid inhibits tyrosinase, the enzyme that starts melanin synthesis. That is a well-characterised mechanism and it is the reason the ingredient is used in products positioned for uneven tone and dark spots. It does not remove existing pigment quickly, and a product promising a visible change in a week is promising something the mechanism does not deliver.

2. The useful dose

Leave-on products typically use one to two percent. Below one percent the effect is modest and the ingredient is present mainly for the label. Above two percent the irritation risk rises faster than the benefit, and in rinse-off products the contact time is too short to justify a high dose.

3. Stability

Kojic acid discolours in light, heat and air, and the discolouration is the ingredient oxidising. A product that turns brown in the jar has lost potency and looks defective. An opaque or airless pack, a chelator in the formula and a cool storage recommendation are the practical controls.

4. pH window

The ingredient is more stable in a mildly acidic environment and less stable as pH rises. A formula buffered near the skin’s own pH is easier to stabilise than an alkaline one. A formulator raising pH for a different active in the same product will usually lose the kojic acid.

5. Irritation and the patch test

Kojic acid can sting, and the risk rises with dose, with a low pH and with a damaged barrier. A patch test in the development file is not optional for a leave-on product at the top of the dose range, and the consumer instruction should say to introduce the product gradually.

6. Combinations

Kojic acid is usually combined with niacinamide, arbutin, vitamin C derivatives or tranexamic acid. The combinations work because they act at different points, and a well-built combination at one percent each is usually better tolerated than a single ingredient at three percent.

7. Claim limits

Brightening is a cosmetic claim in most markets and a medicinal claim once it promises treatment of a condition. Wording such as “helps reduce the appearance of uneven tone” is defensible; wording that names a disorder is not. The claim should be checked against the market where the product is sold, not only where it is made.

8. Analytical control

The raw material should arrive with a certificate of analysis stating assay and the main impurity, and the finished product should be tested at release. A specification without an assay method is a specification that cannot be checked, and kojic acid is an ingredient where the difference between grades shows up in colour.

9. Packaging

Opaque. Airless is better than a jar. A dropper in a clear bottle is the worst combination for this ingredient and it is also the most common. If the pack has to be clear, the formula needs a stronger antioxidant system and a shorter shelf life.

10. Where it fits

Kojic acid appears in the serum range and in targeted brightening products within the cream range. The emulsion decision behind those bases is covered in O/W versus W/O emulsion.